Vytrus Biotech, the company specialized in the development of biotechnological active ingredients for the cosmetic industry, is making a strategic shift in its business model. The Catalan firm, based in Terrassa, has announced an expansion of its scientific and commercial roadmap to diversify its technological portfolio beyond plant stem cell cultures (totipotent cells), its historical core specialization.
This strategic evolution seeks to provide the company with greater competitiveness in the global market for cosmetic ingredients (skin care and hair care). By incorporating new production methodologies and nature-based biotechnological platforms, Vytrus aims to accelerate the launch of innovative active ingredients that respond to the demands for efficacy, sustainability, and "green chemistry" required by major international cosmetic manufacturers.
Since its foundation by Albert Jané and Òscar Expósito, Vytrus has based its success and its subsequent leap to BME Growth on a patented technology that harnesses the potential of plant stem cells to generate high value-added active ingredients with minimal water and soil consumption.
The new phase of the biotech company's expansion will keep sustainability at its core, but will open up to new botanical extraction technologies and bioprocesses. This diversification will not only enrich its product catalog, but will also allow the company to optimize development costs, shorten time-to-market, and access new niches within the beauty and personal care sector.
Financial boost and international projection
The strategic move aligns with the growth objectives shared with its shareholders and investors. After consolidating a solid global distribution network that already covers the main cosmetic markets (Europe, United States, Asia, and Latin America), Vytrus seeks with this business expansion to increase the average ticket of its B2B operations and position itself as a comprehensive provider of biotechnological solutions for premium and mass-market cosmetic brands.
With this diversification, Vytrus Biotech not only strengthens its innovative muscle within the Spanish biotechnological ecosystem, but also positions itself more solidly to capture the opportunities of a global market for active cosmetic ingredients that increasingly values scientific evidence combined with environmental respect.